Nicoccino will, through its patented product platform, offer an attractive Nicotine Replacement Therapy product which is the most effective on the market.
The business model is based on introducing the product platform to international partners that wish to establish themselves in the market of Nicotine Replacement Therapy (NRT) or want to expand their existing product portfolio, and to launch the product themselves globally or in different regions.
The licensing model could mean that the strategy is adapted to the conditions for each respective geographical area. Partnerships can also be established at earlier stages of the clinical approval process.
The business model can also mean sales of patent and licensing of patents.
Production and logistics are outsourced to external partners.